Ola Dale

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Emergency Medical

Chronic Rhinosinusitis

Top Venues

Clinical pharmacokinetics

Addiction (Abingdon, England)

European journal of clinical pharmacology

Expert opinion on drug metabolism & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Teijo I Saari, Sir John Strang, Ola Dale
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical pharmacokinetics 63 (4) (2024)
Teijo I Saari, Sir John Strang, Ola Dale
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical pharmacokinetics 63 (4) (2024)
Teijo I Saari, Sir John Strang, Ola Dale
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical pharmacokinetics (2024)
Teijo I Saari, Sir John Strang, Ola Dale
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical pharmacokinetics 63 (4) (2024)
Teijo I Saari, Sir John Strang, Ola Dale
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical pharmacokinetics 63 (4) (2024)
Desiree Madah-Amiri, Linn Gjersing, Aksel Wüsthoff Danielsen, Arnre Kristian Skulberg, Ola Dale, Anne-Catherine Braarud, Fridtjof Heyerdahl, Ida Tylleskär
Heightened mortality risk after a non-fatal opioid overdose: Risk factors for mortality in the week following emergency treatment. Addiction (Abingdon, England) (2024)
Ola Dale
Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert opinion on drug metabolism & toxicology 18 (3) (2022)
Arnre Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne-Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo, Ola Dale
Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Addiction (Abingdon, England) 117 (6) (2022)
Ida Tylleskar, Arne Kristian Skulberg, Sissel Skarra, Turid Nilsen, Ola Dale
Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil. European journal of clinical pharmacology 74 (12) (2018)